Trident Texofab Ltd shares in focus as exchange gets disclosure for Hardik Desai Family Trust
Why did Trident Texofab Ltd shares fall today?
Shares of Trident Texofab Ltd fell by 0.26% on Thursday, trading at ₹23.33 as of 09:51 AM. This slight dip in the stock price came after the company received a regulatory disclosure from the Hardik Desai Family Trust, which is part of the promoter group.
The disclosure, submitted to the stock exchange, is a mandatory filing under the SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. According to the document, the trust, headed by trustee Hardik Desai, formally notified the company and the BSE about the transaction details, which involved the acquisition of shares. The filing confirms the trust's position within the promoter group and provides the required transactional information to the market.
Such regulatory disclosures, while routine, can sometimes lead to short-term market reactions as investors process the information. The document itself is a procedural compliance by the promoter group entity, confirming their actions in the market as required by securities regulations.
What does Trident Texofab Ltd do?
Trident Texofab Limited is a company listed on the BSE Limited stock exchange with the stock ID "TTFL" and Scrip Code 540726. Its registered address is located at 2004, 2nd Floor, North Extension, Falsawadi, Begumpura, Noidh-4/1650, Sahara Darwaja, Surat-395003, Gujarat.
Trident Texofab Ltd Financials
In CroresTrident Texofab Ltd demonstrated a clear upward trajectory in its financial performance between the March 2026 and June 2026 quarters. Revenue increased from ₹1,632.53 Crores in March 2026 to ₹1,786.83 Crores in June 2026, representing a quarter-over-quarter growth of approximately 9.45%. Alongside the top-line expansion, the company's profit also showed significant improvement, rising from ₹101.98 Crores in March 2026 to ₹158.09 Crores in June 2026, which marks a robust growth of about 55.02%. Notably, profit grew at a substantially faster rate than revenue, suggesting improved operational efficiency or better cost management during the period. Overall, the data reflects a positive growth trend for Trident Texofab Ltd across both revenue and profitability metrics.
Trident Texofab Ltd Shareholding Pattern
Promoter holding stands at 32.16% of the total share capital. Foreign Institutional Investors (FIIs) hold 0.0% stake in the company, while Domestic Institutional Investors (DIIs) hold 0.0%. Public shareholders hold the remaining 67.85% stake in Trident Texofab Ltd.
Trident Texofab Ltd FAQs
Q: Why did Trident shares fall 0.26% today?
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Hardik Desai Family Trust. This corporate action caught investor attention, leading to increased trading activity in the stock.
Q: What is the shareholding pattern of Trident Texofab Ltd?
As per the latest data, promoters hold 32.16% stake in Trident Texofab Ltd, while FII holding stands at 0.0%. Domestic institutional investors hold 0.0%, and public shareholders account for 67.85% of the equity.
Q: What is the current stock price of Trident Texofab Ltd?
Trident Texofab Ltd shares are currently trading at ₹23.33, recording a decline of 0.26% from the previous close.
Q: What is the market capitalization of Trident Texofab Ltd?
The company currently has a market capitalization of ₹11888.0 crore, reflecting its valuation in the Indian equity market.